UBS Group’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55,900
| Closed | -$593K | – | 9528 |
|
|
2024
Q1 | $593K | Buy |
55,900
+8,800
| +19% | +$77K | ﹤0.01% | 5061 |
|
|
2023
Q4 | $378K | Buy |
+47,100
| New | +$343K | ﹤0.01% | 5320 |
|
|
2023
Q3 | – | Sell |
-120,000
| Closed | -$960K | – | 9465 |
|
|
2023
Q2 | $960K | Sell |
120,000
-27,200
| -18% | -$201K | ﹤0.01% | 4290 |
|
|
2023
Q1 | $1.19M | Buy |
147,200
+58,100
| +65% | +$467K | ﹤0.01% | 3960 |
|
|
2022
Q4 | $560K | Sell |
89,100
-60,000
| -40% | -$419K | ﹤0.01% | 4612 |
|
|
2022
Q3 | $1.03M | Hold |
149,100
| – | – | ﹤0.01% | 3736 |
|
|
2022
Q2 | $1.25M | Sell |
149,100
-796,300
| -84% | -$11.1M | ﹤0.01% | 3547 |
|
|
2022
Q1 | $21.6M | Buy |
945,400
+672,900
| +247% | +$16.4M | 0.01% | 1358 |
|
|
2021
Q4 | $7.52M | Buy |
+272,500
| New | +$7.29M | ﹤0.01% | 2402 |
|
|
2020
Q1 | – | Sell |
-118,630
| Closed | -$3.55M | – | 7960 |
|
|
2019
Q4 | $3.55M | Buy |
118,630
+4,730
| +4% | +$123K | ﹤0.01% | 2937 |
|
|
2019
Q3 | $2.49M | Sell |
113,900
-3,480
| -3% | -$79.6K | ﹤0.01% | 3089 |
|
|
2019
Q2 | $2.96M | Buy |
117,380
+1,250
| +1% | +$29.7K | ﹤0.01% | 2796 |
|
|
2019
Q1 | $2.87M | Sell |
116,130
-127,250
| -52% | -$3.04M | ﹤0.01% | 2664 |
|
|
2018
Q4 | $4.5M | Sell |
243,380
-160,150
| -40% | -$3.81M | ﹤0.01% | 2252 |
|
|
2018
Q3 | $10.4M | Buy |
403,530
+61,011
| +18% | +$1.4M | ﹤0.01% | 1752 |
|
|
2018
Q2 | $7.96M | Sell |
342,519
-479,481
| -58% | -$9.91M | ﹤0.01% | 1933 |
|
|
2018
Q1 | $13.1M | Buy |
822,000
+13,500
| +2% | +$251K | 0.01% | 1471 |
|
|
2017
Q4 | $16.8M | Buy |
808,500
+229,000
| +40% | +$3.63M | 0.01% | 1309 |
|
|
2017
Q3 | $8.3M | Sell |
579,500
-314,900
| -35% | -$4.76M | ﹤0.01% | 1758 |
|
|
2017
Q2 | $15.5M | Buy |
894,400
+694,400
| +347% | +$8.32M | 0.01% | 1205 |
|
|
2017
Q1 | $2.21M | Sell |
200,000
-12,300
| -6% | -$169K | ﹤0.01% | 2862 |
|
|
2016
Q4 | $3.08M | Buy |
212,300
+10,471
| +5% | +$192K | ﹤0.01% | 2524 |
|
|
2016
Q3 | $4.96M | Buy |
201,829
+63,003
| +45% | +$1.63M | ﹤0.01% | 2034 |
|
|
2016
Q2 | $2.8M | Sell |
138,826
-984,485
| -88% | -$27.9M | ﹤0.01% | 2489 |
|
|
2016
Q1 | $29.5M | Sell |
1,123,311
-3,713,047
| -77% | -$275M | 0.02% | 673 |
|
|
2015
Q4 | $492M | Buy |
4,836,358
+4,716,258
| +3,927% | +$530M | 0.32% | 59 |
|
|
2015
Q3 | $21.4M | Buy |
120,100
+119,800
| +39,933% | +$27.9M | 0.02% | 862 |
|
|
2015
Q2 | $67K | Sell |
300
-1,800
| -86% | -$399K | ﹤0.01% | 5734 |
|
|
2015
Q1 | $417K | Sell |
2,100
-210,600
| -99% | -$37.4M | ﹤0.01% | 4285 |
|
|
2014
Q4 | $30.4M | Buy |
+212,700
| New | +$28.6M | 0.02% | 748 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
UBS Group's BHC Position: Q1 2026 in Review
UBS Group increased its Bausch Health (BHC) stake by 72% in Q1 2026, buying an estimated $2.6M and bringing the position to 1,041,848 shares worth $5.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3961.
UBS Group first reported a position in BHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $132M in Q4 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- UBS Group held 1,041,848 shares of Bausch Health worth $5.63M as of Q1 2026.
- UBS Group bought 434,371 Bausch Health shares in Q1 2026, an estimated $2.6M.
- Bausch Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3961 holding.
- UBS Group first reported a position in Bausch Health in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Bausch Health position peaked at $132M in Q4 2015.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.